HELIX BIOMEDIX INC - FORM 10-Q - EX-32.1 - CERTIFICATION OF THE CEO PURSUANT TO 18 U.S.C. SECTION 1350 - August 5, 2010

Attached files

file filename
10-Q - FORM 10-Q - HELIX BIOMEDIX INCd10q.htm
EX-31.1 - CERTIFICATION OF THE CEO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) - HELIX BIOMEDIX INCdex311.htm
EX-31.2 - CERTIFICATION OF THE ACTING CFO PURSUANT TO RULE 13A-14(A) OR RULE 15D-14(A) - HELIX BIOMEDIX INCdex312.htm
EX-32.2 - CERTIFICATION OF THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 - HELIX BIOMEDIX INCdex322.htm
EX-10.20 - SUPPLY AGREEMENT DATED AS OF JULY 1, 2010 - HELIX BIOMEDIX INCdex1020.htm
EX-10.18 - MEMBERSHIP INTEREST AGREEMENT DATED AS OF JULY 1, 2010 - HELIX BIOMEDIX INCdex1018.htm
EX-10.7(B) - SECOND AMENDMENT TO FIRST AMENDED AND RESTATED LICENSE AGREEMENT - HELIX BIOMEDIX INCdex107b.htm
EX-10.19 - AMENDED AND RESTATED OPERATING AGREEMENT OF NUGLOW COSMACEUTICALS, LLC - HELIX BIOMEDIX INCdex1019.htm

Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350

I, R. Stephen Beatty, President and Chief Executive Officer of Helix BioMedix, Inc. (the “Company”), certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2010 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 5, 2010

 

/s/    R. Stephen Beatty

R. Stephen Beatty

President and Chief Executive Officer

Stock widget

Investing forum

HELIX BIOMEDIX INC Reports